Mark S. DiIorio, Ph.D. President & CEO, Chairman of the Board
Dr. DiIorio has been CEO of MagneSensors since founding the company in 1997. He has been responsible for funding the company through research and development grants and contracts and also established numerous collaborations with universities, hospitals, and industry. Previously he was Vice President of Technology at Biomagnetic Technologies, where he spent 10 years in various management positions, reporting directly to the CEO from 1990-1997. At Biomagnetic Technologies, he established the superconductor core technology group, which was recognized as one of the world leaders in superconducting sensor technology. This core technology was transferred to MagneSensors, where it has benefitted from further development. He also worked as a Staff Member at MIT Lincoln Laboratory for two years. Dr. DiIorio received an A.B. from Dartmouth College (Summa Cum Laude, Phi Beta Kappa) and a Ph.D. in Applied Physics from Stanford University in 1985, where his thesis research focused on superconducting sensor technology. He has over 30 years experience in the area of superconducting devices, including numerous patents and publications.
Kai Yang, Ph.D. Vice President, Research & Development
Dr. Yang guides the research and development effort in MagneSensors’ sensor technology and is centrally involved in the instrumention development. He has 20 years experience in all aspects of the core technology and he has directed the sensor fabrication and processing as well as instrument measurement efforts. Prior to joining MagneSensors, Dr. Yang was a Senior Physicist for ten years at Biomagnetic Technologies. Dr. Yang has a Ph.D. in Physics from Case Western University followed by a two year post-doctoral position at Argonne National Laboratory.
Board of Directors
D. Scott Buchanan, Ph.D. President, Fawkes Consulting LLC
Dr. Buchanan is the President of Fawkes Consulting, a firm he founded to leverage his diverse skills ranging from business development to product design. Previously, he spent 12 years as President & CEO of 4D Neuroimaging. During his time there Dr. Buchanan raised over $60 million to help 4D Neuroimaging develop and sell medical instrumentation to examine brain function. He has guided diverse areas including multi-center clinical trials, product development, product applications, operations and GMP/QSR compliant manufacturing. Dr. Buchanan has a Ph.D. in Physics from the University of Illinois.
Aron P. Stern, M.B.A. Vice President and Chief Financial Officer, Vital Therapies, Inc.
Mr. Stern has over 20 years of experience in capital formation, acquisitions, financial strategy and financial, and operational management in growth-stage high technology and biotechnology companies. During his financial career he has assisted with two IPOs and numerous private placements, helping to raise over $100 million. He has held the position of Vice President of Finance and Administration and CFO at VitaGen, Biomagnetic Technologies, and Protein Polymer. He also worked at Apple Computer and Isis Pharmaceuticals. Mr. Stern received a B.S. in Economics and Business Administration and an M.B.A. in Finance and Marketing from the University of California, Berkeley.
Mark S. DiIorio, Ph.D. President & CEO, Chairman of the Board